Gregory F. Murphy Stock Trades

Gregory F. Murphy Congressional Trading Profile | Quantellect Gregory F. Murphy Congressional Trading Profile

Gregory F. Murphy's disclosure record does not describe active trading. It shows a small number of sales spread across several years. Across the full span of the available transaction data, from October 2019 through May 2022, the North Carolina Republican reported exactly three transactions, and every one of them was a sale.

That pattern alone tells much of the story. There are no purchases anywhere in the supplied record. Instead, the three entries cover a Medical Bond Redemption, Nymox Pharmaceutical Corporation, and a condominium in Raleigh, North Carolina. The activity amounts to one disclosed sale in 2019, one in 2021, and one in 2022, with no repeated security name.

What was sold, and when

The earliest disclosed transaction was a "Medical Bond Redemption," sold on October 23, 2019, in the $50,001 to $100,000 range and disclosed on November 3, 2019. The packet supplies no ticker, company name, sector, industry, or company description for this entry, so the disclosure does not support a more specific classification.

More than a year later, on January 22, 2021, Murphy reported a sale of Nymox Pharmaceutical Corporation (NYMX) in the $50,001 to $100,000 range. The transaction was disclosed on February 12, 2021. NYMX is the single most frequently disclosed security in his record, though "most frequently disclosed" here means it appears in one transaction. No company description, sector, or industry data accompanies the entry.

The most recent and largest disclosed transaction came on May 1, 2022: the sale of an entry identified in the record as "Condominium - Raleigh, NC," in the $250,001 to $500,000 range. It was disclosed on June 8, 2022. Its reported amount range is higher than those of the other two transactions, and it marks the last disclosed transaction in the available record.

All three transactions are attributed to Murphy personally. None is attributed to a spouse, dependent child, joint interest, or unknown relationship. Sector data is listed as unknown across all three entries. The packet contains transaction disclosures only, so the article does not extend those reported sales into claims about Murphy's broader finances.

Disclosure cadence and Quantellect scoring

Murphy's disclosed activity is sparse and irregular in the supplied record. One sale appears in 2019, followed by one in 2021 and one in 2022. There are no reported purchases or other transaction types among the three entries, and the packet lists no additional transaction after the condominium sale dated May 1, 2022.

Murphy also does not carry a Quantellect Score as of the latest published scoring date, August 21, 2026. The reason supplied in the data is narrow: no score row exists for him on that date. Accordingly, the packet provides no score, tier, coverage state, cohort rank, or cohort size for Murphy. The absence of a score is not presented as a judgment about his conduct.

For a reader trying to draw a signal from congressional disclosures, Murphy's file offers a limited record: three sales across three separate years, with no purchases and no security appearing more than once. One entry is identified as a Medical Bond Redemption, one names NYMX, and one names a Raleigh condominium. That supports a description of infrequent, sale-only disclosed activity, but not a conclusion about an ongoing investment strategy or the reasons behind the transactions. All three underlying filings are linked below for readers who want to review the original documents directly.

Disclosure and methodology

This Quantellect profile is built from transaction data disclosed under the Stop Trading on Congressional Knowledge Act of 2012 and presented within the House financial disclosure framework described by the House Committee on Ethics financial disclosure instruction guide. Periodic Transaction Reports disclose transaction value categories rather than exact amounts. The transaction dates and disclosure dates above are reported separately, and this profile is limited to the transaction-level activity supplied in the record. Source filings: 2019 PTR, 2021 PTR, 2022 PTR.